4
Changes in Ownership
Faeth Therapeutics, Inc. Filed Acc 0001567619-22-001165
10% owner bought 20,047 shares at an average $5.20 ($104,212)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cambrian BioPharma Inc 10% owner | 2022-01-11 | Purchase | +10,845 | $5.18 | $56,177 | 4,940,258 | D: show line 1 in the form |
| Cambrian BioPharma Inc 10% owner | 2022-01-12 | Purchase | +9,202 | $5.22 | $48,034 | 4,949,460 | D: show line 2 in the form |
| Open-market purchases · 20,047 sh · avg $5.20 · $104,212 | |||||||
Loading xslF345X03/doc1.xml…